Automated Connective Tissue Torque Sensor

Stromatec, Inc.165 enrolled

Overview

The purpose of this study is to develop a measure - the needle torque test - capable of detecting connective tissue abnormalities associated with musculoskeletal disorders.

Chronic musculoskeletal pain is a source of considerable disability, work absenteeism and health care costs. A major obstacle to the treatment of these conditions is the lack of methods to objectively assess connective tissues and measure the effect of treatments. Needle torque test technology under development in this project will potentially enable objective measurement of connective tissue abnormalities associated with musculoskeletal pain and dysfunction. This could help evaluate the efficacy of various treatments and enhance the objective monitoring of patient progress in clinical practice.

Study Type

OBSERVATIONAL

Enrollment

165

Conditions

Connective Tissue Musculoskeletal Pain

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria for chronic low back pain subjects: * back pain that has disrupted activity for more than half the days in the past 12 months. Inclusion Criteria for restricted hamstring subjects: * 90/90 test of more than 20 degrees Inclusion Criteria for systemic scleroderma subjects: * physician diagnosis Inclusion criteria for joint hyperlaxity subjects: * Beighton test score of 7 or higher Exclusion Criteria for all subjects: * surgery or scars in thighs or low back * neurological or major psychiatric disorder * bleeding disorders * acute systemic infection * pregnancy

Locations (1)

Stromatec, Inc.

Burlington, Vermont, United States

Outcomes

Primary Outcomes

Number of needle revolutions to achieve threshold torque

Time frame: Time zero, 30 minutes and one week

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.